Navigation Links
Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimer's Patent Application
Date:11/3/2011

clinical development and is licensed to major pharmaceutical companies.  The company's RECALL-VAX technology is a proprietary Alzheimer's vaccine with therapeutic and prophylactic potential.   The company's CONJUMAB-A platform is based on antibody drug conjugates with potential applications to treat a broad spectrum of proteinopathies including Alzheimer's disease, Early-Onset Familial Alzheimer's disease, cerebral angiopathy, age-related macular degeneration, glaucoma and traumatic brain injury. IN-N01-OX2 is the company's most advanced internal candidate, a humanized monoclonal antibody targeting beta amyloid conjugated to a naturally occurring small drug molecule with potent neuroprotective properties.  Thus, IN-N01-OX2, incorporates combined features of the ANTISENILIN and CONJUMAB-A platform technologies. The company recently licensed OX1 a small molecule multimodal antioxidant to ViroPharma, Inc. for Friedreich's Ataxia and other neurodegenerative diseases.

Safe Harbor Statement Regarding Forward-Looking Statements:

The statements in this release and oral statements made by representatives of Intellect relating to matters that are not historical facts (including, without limitation, those  regarding future performance or financial results, the timing or potential outcomes of research collaborations or clinical trials, any market that might develop for any of Intellect's product candidates and the sufficiency of Intellect's cash and other capital resources) are forward-looking statements that involve risks and uncertainties, including, but not limited to, the likelihood that actual performance or results could materially differ, that future research will prove successful, the likelihood that any product in the research pipeline will receive regulatory approval in the United States or abroad, or Intellect's ability to fund such efforts with or without partners. Intellect undertakes no obligation to update any of these
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimers Disease and Other Proteinopathies
2. Intellect Neurosciences Issues Letter to Shareholders
3. Intellect Neurosciences CEO to be Featured on Wall Street Reporter
4. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
5. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
6. PILMA Vows to Redouble Support for Increased Protections Against Intellectual Property Theft
7. Dehaier Strengthens Intellectual Property Portfolio
8. NMT Medical, Inc. Adds Intellectual Property to Its Sealed Bid Sale of Friday, June 10, 2011 at Twelve OClock Noon
9. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
10. Inovio Pharmaceuticals Market-Leading Intellectual Property Recognized by MDB Capital Award
11. NMT Medical, Inc. Sealed Bid Sale of its Intellectual Property to Take Place Friday, June 10, 2011 at Twelve OClock Noon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , March 6, 2015 ... validation from Intuitive Surgical, the manufacturer of ... Triton-36 Instrument Cleaning System. This approval reflects the ... in cleanliness currently in place for the sterile ... validation for reprocessing robotic surgical instruments for re-use. ...
(Date:3/6/2015)... R.I. , March 6, 2015 Troyen ... Medical Officer of CVS Health (NYSE: CVS ... Health in Washington, D.C. today. ... critical role in addressing health care cost and quality ... After making CVS/pharmacy the first national pharmacy chain to ...
(Date:3/6/2015)... WILMINGTON, Del. , March 6, 2015 /PRNewswire/ ... Patent and Trademark Office,s publication of U.S. Patent ... Eating Disorder."  The ,249 Patent Application features claimed methods ... may be used to treat Binge Eating Disorder ... "information material," or "flyer or an advertisement," as ...
Breaking Medicine Technology:Ultra Clean Systems Reaches Exclusive Place within Robotic Surgical Instrument Cleaning Industry with Latest Certifications 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 3Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2
... 2011 As the nation seeks to expand ... burdensome costs, researchers from Harvard University, Brigham and ... CVS ) reported that preventative health care may ... to expanded use of cost-effective generic medications for ...
... WOODCLIFF LAKE, N.J., July 6, 2011 Par Pharmaceutical Companies, ... will host a conference call and live webcast on Wednesday, ... for the second quarter 2011. The Company will release its ... Access to the live webcast can be made ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 2CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 3CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 4
(Date:3/6/2015)... 06, 2015 Ticket Down is a reputable ... at the Moda Center. After being away from ... is showing no signs of letting up on his “Garth ... and his wife, Trisha Yearwood, to venues around the United ... their critically acclaimed tour to the Moda Center in Portland, ...
(Date:3/6/2015)... As the Muscular Dystrophy Association continues to enhance its ... two new Scientific Program Officers, Amanda Haidet-Phillips, Ph.D and ... Pavlath, Ph.D, who joined MDA late last year as ... will lead MDA as it accelerates new front-line discovery ... of neuromuscular and motor neuron diseases. , ...
(Date:3/6/2015)... CA (PRWEB) March 06, 2015 US ... of three Maryland camps – two non-contact specialty camps ... be run by Perfect Performance Training, located at Bowie ... focus on developing position specific skills, speed and strength ... hosted at Salisbury University with Marvin Graves, former quarterback ...
(Date:3/6/2015)... Bakersfield, California (PRWEB) March 06, 2015 ... $5.7 million jury verdict on March 5, 2015 in ... County. According to court documents, a jury of 12 ... she suffered from being implanted with an Ethicon TVT ... of nine men and three women also awarded $5 ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Jvion, ... the release of a Clostridium Difficile (C Diff) ... The C Diff use case is the latest ... span hospital acquired infections, chronic conditions, and individual ... the C Diff solution flags at risk individuals ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... that absorbs blue light has been linked to sleep disorders in ... 1 issue of the journal Sleep . As this type ... insomnia. "The strong link between lens yellowing and age could ... said Line Kessel, M.D., Ph.D., the study,s lead author. In ...
... of the speech information rate of seven languages concludes ... which languages are spoken, but much less variation in ... "A cross-linguistic perspective on speech information rate," to be ... journal Language , is co-authored by Franois Pellegrino, ...
... HealthDay Reporter , WEDNESDAY, Aug. 31 (HealthDay ... records instead of paper files could greatly improve care ... "did better and improved faster" at various kinds of ... author Dr. Randall D. Cebul, a professor of medicine ...
... WEDNESDAY, Aug. 31 (HealthDay News) -- Some breast cancer patients ... can skip hormone therapy without increasing their risk of death, ... had tumors that were hormone-receptor positive, which means they require ... tumors is designed to starve the breast cancer cells by ...
... modified a toxic chemical produced by tiny marine microbes and ... Writing today in ACS Medicinal Chemistry Letters , UF ... of marine cyanobacteria and made it more specifically toxic ... of the compound to mice with a form of colon ...
... an easy way to improve your health: trust your neighbors. ... that increasing trust in neighbors is associated with better self-reported ... where one fits into the income distribution in their local ... self-rated health," said Eileen Bjornstrom, an assistant professor of sociology ...
Cached Medicine News:Health News:Aging eyes linked to sleepless nights, new study shows 2Health News:Language speed versus efficiency: Is faster better? 2Health News:Electronic Medical Records Might Boost Diabetes Care 2Health News:Electronic Medical Records Might Boost Diabetes Care 3Health News:Some Older Breast Cancer Patients Can Skip Hormone Therapy: Study 2Health News:Some Older Breast Cancer Patients Can Skip Hormone Therapy: Study 3Health News:UF medicinal chemists modify sea bacteria byproduct for use as potential cancer drug 2Health News:UF medicinal chemists modify sea bacteria byproduct for use as potential cancer drug 3Health News:Trust in your neighbors could benefit your health, MU study shows 2
... Rusch Snap-Light™ laryngoscope blades are designed with ... fiber optic bundle can be removed to ... to reach areas. Our unique snap-on mechanism ... bright focused blades are interchangeable with other ...
... high quality fiberoptic system designed to meet ... fiberoptic laryngoscopes. The green color coding identifies ... to interconnect with other green coded systems. ... bright and focused light. The Greenspec pivot ...
Rigid plastic. Single use. Non-Sterile. The disposable laryngoscope blade that fits on a standard handle. Made of extremely rigid plastic. Bright white light out-performs metal blades. Single patient...
... Laryngoscopes are a high quality fiberoptic system ... greater standardization to fiberoptic laryngoscopes. The green ... indicates it's ability to interconnect with other ... offers a cool, bright and focused light. ...
Medicine Products: